Innoviva actively pursues a robust Innoviva digital transformation strategy, focusing on integrating advanced systems across its critical biopharmaceutical operations. This strategy involves digitizing complex workflows within clinical development, regulatory affairs, and research data management to enhance precision and compliance. Innoviva’s approach emphasizes building interconnected digital infrastructure that directly supports drug discovery, clinical trials, and market access, moving away from disparate tools and manual processes.
This extensive Innoviva digital transformation introduces critical dependencies on system interoperability, data integrity, and automated process controls. Failures in data propagation between platforms or inconsistencies in regulatory submissions create significant operational risks and delays in drug development timelines. This page analyzes Innoviva’s key initiatives, identifies specific challenges arising from these transformations, and outlines clear opportunities for sellers to address these critical control points.
Innoviva Snapshot
Headquarters: Burlingame, CA, United States
Number of employees: 159 employees
Public or private: Public
Business model: B2B
Website: http://www.inva.com
Innoviva ICP and Buying Roles
Innoviva sells to organizations with complex drug development pipelines and companies operating within highly regulated pharmaceutical sectors.
Who drives buying decisions
-
Head of Clinical Operations → Directs the efficiency and compliance of clinical trial execution.
-
VP of Regulatory Affairs → Manages all aspects of drug approval and regulatory submissions.
-
Chief Scientific Officer → Oversees research strategies and data utilization for drug discovery.
-
Chief Financial Officer → Approves major investments in enterprise-wide operational systems.
Key Digital Transformation Initiatives at Innoviva (At a Glance)
-
Implementing Clinical Data Management Systems for trial execution and monitoring.
-
Integrating Regulatory Information Management (RIM) platforms for global submissions.
-
Constructing R&D Data Lakes for centralizing scientific datasets.
-
Upgrading Enterprise Resource Planning (ERP) systems for core business functions.
Where Innoviva’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Trial Optimization | Clinical Data Management System implementation: patient data entry errors occur before validation. | Head of Clinical Operations | Validate clinical data at source before system ingestion. |
| Clinical Data Management System implementation: trial monitoring reports do not reflect real-time site activity. | Clinical Trial Manager | Standardize data refresh rates across monitoring dashboards. | |
| Clinical Data Management System implementation: adverse event reporting does not route to safety teams immediately. | Clinical Operations Lead, Head of Safety | Route critical safety events to relevant teams in real time. | |
| Regulatory Compliance & Reporting | Regulatory Information Management (RIM) system integration: submission documents contain outdated annexes. | VP of Regulatory Affairs, Regulatory Operations Lead | Detect version discrepancies in regulatory submission packages. |
| Regulatory Information Management (RIM) system integration: regional variations block global submission workflows. | Regulatory Affairs Manager | Enforce regional submission requirements before publishing. | |
| Regulatory Information Management (RIM) system integration: audit trails do not capture all document changes. | Head of Quality Assurance | Standardize comprehensive change logging for all regulatory assets. | |
| Scientific Data Platforms | R&D Data Lake construction: experimental data from labs fails to load into the central repository. | Chief Scientific Officer, Head of Data Science | Validate data schema compatibility during ingestion from lab instruments. |
| R&D Data Lake construction: data query results show inconsistencies across different research projects. | Research Scientist, Data Analyst | Standardize data definitions across linked research datasets. | |
| R&D Data Lake construction: access controls do not restrict sensitive genomic data by user role. | Head of IT Security, Data Governance Lead | Enforce granular access permissions for sensitive research data. | |
| Enterprise System Modernization | Enterprise Resource Planning (ERP) system upgrade: procurement requests do not propagate to vendor management. | CFO, VP of Procurement | Route purchase orders directly from ERP to vendor systems. |
| Enterprise Resource Planning (ERP) system upgrade: financial reporting data does not reconcile with general ledger. | Head of Finance, Corporate Controller | Detect variances between sub-ledgers and the general ledger. | |
| Enterprise Resource Planning (ERP) system upgrade: HR employee records do not update compensation data correctly. | Head of HR Operations, Payroll Manager | Validate data consistency between HRIS and payroll modules. |
Identify when companies like Innoviva are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Innoviva’s digital transformation unique
Innoviva prioritizes stringent compliance and rapid data utilization within a highly regulated scientific environment, differentiating its Innoviva digital transformation. Its focus involves creating interconnected systems that prevent data fragmentation during clinical trials and regulatory submissions, crucial for accelerating drug development. This approach is more complex than typical enterprise transformations, as it must adhere to strict regulatory guidelines like FDA 21 CFR Part 11 and manage highly sensitive patient and research data. Innoviva’s transformation directly impacts critical milestones for bringing new therapies to market.
Innoviva’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Data Management System Implementation
What the company is doing
Innoviva is centralizing patient data collection and monitoring processes through a new Clinical Data Management System. This system manages electronic data capture from investigator sites and provides tools for real-time trial oversight. It processes patient demographics, treatment responses, and adverse events from ongoing clinical studies.
Who owns this
-
Head of Clinical Operations
-
Clinical Data Manager
-
Clinical Project Lead
Where It Fails
-
Patient reported outcomes do not reconcile with site-entered data before locking.
-
Clinical monitoring visit reports contain discrepancies against source data in EDC.
-
Protocol deviations are not flagged consistently across all active study sites.
-
Data queries from sites do not route to the correct data managers for resolution.
Talk track
Noticed Innoviva is implementing Clinical Data Management Systems for trial execution. Been looking at how some biopharma teams are validating clinical data at the point of entry instead of cleaning it later, can share what’s working if useful.
DT Initiative 2: Regulatory Information Management (RIM) System Integration
What the company is doing
Innoviva is integrating a Regulatory Information Management system to consolidate all regulatory assets and submission workflows. This system centralizes document authoring, manages version control, and standardizes submission packaging for various health authorities. It tracks regulatory commitments and approval statuses across the product lifecycle.
Who owns this
-
VP of Regulatory Affairs
-
Regulatory Operations Lead
-
Head of Quality Assurance
Where It Fails
-
Submission documents do not link to approved local product labels across regions.
-
Version conflicts arise when multiple users edit regulatory dossiers concurrently.
-
Mandatory fields in submission forms are left blank before final validation.
-
Approval workflows for regulatory content do not route to all required stakeholders.
Talk track
Saw Innoviva is integrating Regulatory Information Management platforms for global submissions. Been looking at how some biopharma teams are detecting version discrepancies in regulatory assets before submission instead of after, happy to share what we’re seeing.
DT Initiative 3: R&D Data Lake Construction
What the company is doing
Innoviva is building an R&D Data Lake to unify disparate scientific data sources from research labs and preclinical studies. This initiative aims to centralize genomics, proteomics, and imaging data for advanced analytics. It provides a single repository for researchers to access and query integrated datasets for drug discovery.
Who owns this
-
Chief Scientific Officer
-
Head of Data Science
-
Director of Bioinformatics
Where It Fails
-
Raw instrument data does not parse correctly into the data lake schemas upon ingestion.
-
Cross-study queries yield inconsistent results due to varying data taxonomies.
-
Access permissions for sensitive patient-derived data are not enforced at the dataset level.
-
Data lineage tracking does not capture all transformations applied to raw research data.
Talk track
Looks like Innoviva is constructing R&D Data Lakes for centralizing scientific datasets. Been seeing how some research organizations are validating data schemas during ingestion instead of cleaning in the lake, can share what’s working if useful.
DT Initiative 4: Enterprise Resource Planning (ERP) System Upgrade
What the company is doing
Innoviva is upgrading its core Enterprise Resource Planning (ERP) system to modernize financial, human resources, and supply chain management processes. This upgrade includes consolidating disparate modules into a unified platform. It standardizes procurement, expense reporting, and inventory management workflows across the organization.
Who owns this
-
CFO
-
VP of Procurement
-
Head of Finance Operations
Where It Fails
-
Purchase orders do not sync from the procurement module to the accounts payable system.
-
Employee expense reports are not routed to the correct department managers for approval.
-
Inventory levels in the warehouse management module do not reconcile with the general ledger.
-
Vendor master data entries contain duplicate records across purchasing and payment systems.
Talk track
Seems like Innoviva is upgrading Enterprise Resource Planning (ERP) systems for core business functions. Been looking at how some companies are validating vendor data at the point of entry instead of fixing reconciliation errors downstream, happy to share what we’re seeing.
Who Should Target Innoviva Right Now
This account is relevant for:
-
Clinical data validation and governance platforms
-
Regulatory information and submission management software
-
Scientific data integration and data lake management tools
-
ERP data quality and process control solutions
-
Automated workflow orchestration platforms for compliance
-
Data lineage and metadata management systems
Not a fit for:
-
Generic marketing automation tools
-
Basic project management software
-
E-commerce platforms for direct consumer sales
-
Standalone HR benefits administration systems
When Innoviva Is Worth Prioritizing
Prioritize if:
-
You sell clinical data validation tools that prevent entry errors at the source.
-
You sell regulatory content management solutions that detect version conflicts in submission documents.
-
You sell data integration platforms that standardize research data schemas during ingestion.
-
You sell ERP process control systems that route procurement requests based on established rules.
-
You sell solutions that enforce granular access controls on sensitive research datasets.
Deprioritize if:
-
Your solution does not address any of the specific data or workflow breakdowns identified.
-
Your product is limited to basic administrative tasks without integration capabilities.
-
Your offering is not built for highly regulated environments with strict compliance needs.
Who Can Sell to Innoviva Right Now
Clinical Data Management Solutions
Veeva Systems - This company offers cloud-based software for the life sciences industry, including clinical data management.
Why they are relevant: Clinical trial data errors occur before validation, causing delays. Veeva's products validate data at the point of entry, preventing inconsistencies and ensuring data integrity for regulatory submissions.
Medidata Solutions - This company provides cloud-based solutions for clinical development, including electronic data capture and clinical trial management.
Why they are relevant: Monitoring reports do not reflect real-time site activity, leading to operational blind spots. Medidata’s platform standardizes real-time data flow, providing accurate insights for trial oversight and reducing discrepancies.
Regulatory Compliance Platforms
MasterControl - This company offers quality management system software for regulated industries, including document control and regulatory compliance.
Why they are relevant: Submission documents contain outdated annexes, risking compliance issues. MasterControl's system detects version discrepancies and enforces proper document linking within regulatory submission packages.
IQVIA - This company provides advanced analytics, technology solutions, and clinical research services to the life sciences industry.
Why they are relevant: Regional variations block global submission workflows, creating bottlenecks. IQVIA's solutions standardize global submission requirements, ensuring consistent compliance across different health authorities.
Scientific Data Integration and Governance
Databricks - This company provides a data lakehouse platform that unifies data, analytics, and AI workloads.
Why they are relevant: Raw instrument data fails to parse into data lake schemas, hindering analysis. Databricks' platform validates data schema compatibility during ingestion, ensuring proper structuring of research data.
Collibra - This company offers a data governance and catalog platform, helping organizations understand and trust their data.
Why they are relevant: Cross-study queries yield inconsistent results due to varying data taxonomies. Collibra's platform standardizes data definitions across linked research datasets, improving data consistency for scientific analysis.
ERP Process and Data Controls
Workday - This company provides cloud applications for finance, human resources, and planning.
Why they are relevant: Purchase orders do not sync from the procurement module to accounts payable. Workday's integrated system routes purchase orders directly from ERP to financial systems, enforcing process flow and reducing manual re-entry.
Trintech - This company offers financial close and reconciliation software solutions.
Why they are relevant: Financial reporting data does not reconcile with the general ledger. Trintech's solution detects variances between sub-ledgers and the general ledger, ensuring accurate financial reporting and control.
Final Take
Innoviva is scaling critical clinical, regulatory, and R&D data processes through its Innoviva digital transformation. Breakdowns are visible in data consistency, workflow automation, and system integration within these highly regulated areas. This account is a strong fit for sellers offering solutions that directly address data validation, process routing, and compliance enforcement within complex biopharmaceutical operational frameworks.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.